Table III.
Univariate and multivariate analysis of clinical variables associated with overall survival in patients with lung cancer.
| Univariate | Multivariate univariate | |||
|---|---|---|---|---|
| Characteristics | Category | P-value | HR (95% CI) | P-value |
| Age | ≤69 vs. >69 | 0.172 | ||
| Gender | Male vs. Female | 0.596 | ||
| Maximum tumor size | ≤26 vs. >26 | 0.003 | ||
| Lymph node metastasis | Negative vs. Positive | <0.001 | 4.055 (2.004–8.004) | <0.001 |
| Pleural invasion | Negative vs. Positive | 0.015 | ||
| Venous invasion | Negative vs. Positive | 0.001 | ||
| Pathological stage | Stage I vs. Stage II/III | <0.001 | ||
| Differentiation | Well vs. Moderate/Poor | 0.005 | ||
| Recurrence | Negative vs. Positive | <0.001 | 4.672 (2.264–9.264) | <0.001 |
| CD117 expression | Negative vs. Positive | 0.113 | ||
HR, hazard ratio; CI, confidence interval; CD, cluster of differentiation.